Procedure
Deep brain stimulation (DBS) for movement disorders
Thin wires placed deep in the brain send mild electrical pulses to ease movement symptoms. It is for selected people with Parkinson's disease or essential tremor.
General information, not medical advice. In an emergency call 911. Full disclaimer
What it does
DBS places thin wires (leads) in a small target deep in the brain. They connect under the skin to a pulse generator, like a pacemaker, below the collarbone. The pulses block signals that cause symptoms. [1]
The targets, in plain words. The FDA has approved 3 targets. [2]
- Subthalamic nucleus (STN) and globus pallidus (GPi): small movement centers used for Parkinson's disease. In a trial of 299 people, movement improved about the same with either one. People with STN stimulation needed less medicine. On average, mood got worse after STN and better after GPi stimulation. [3]
- Thalamus (VIM): a relay center used mainly for tremor. [4]
DBS for epilepsy is different. It uses another part of the thalamus (the anterior nucleus). The goal is fewer seizures. In a trial of 110 adults, seizures fell by about half (median 56%) by 2 years. Few became seizure free. [5] See DBS for epilepsy.
When it is considered
- Parkinson's disease with "off" time, dyskinesia (extra movements from medicine), or tremor that medicine has not fixed. The person still gets some benefit from levodopa and has no serious mood or thinking problems. [2]
- Essential tremor when medicine fails or tremor badly limits daily life. [4] One-sided thalamic DBS was first approved in 1997 for arm and hand tremor. [6]
What matters most in the decision
Set goals for each symptom. DBS mainly helps movement. In Parkinson's disease, it can help tremor, stiffness, slowness, "off" time, and dyskinesia. It does not usually help speech, freezing, balance, mood, or memory. [7] [2] [8] For essential tremor, the goal is less hand and arm tremor. [6]
Surgery risk is higher after age 70 and with high blood pressure or blood vessel disease in the brain. [9]
Preparation and what happens
- MRI or CT scans map the target. [9]
- The leads are often placed while you are awake and numb, with your head in a frame. The team may ask you to move or speak to check placement. [1]
- The pulse generator is placed under general anesthesia, the same day or later. A hospital stay of about 3 days is typical. [1]
Expected benefits
The first 3 trials studied people with Parkinson's disease.
- More good hours. In 255 people with advanced disease, DBS added about 4.6 hours a day of good movement without troubling dyskinesia at 6 months. Medicine alone added none. Movement clearly improved in 71 out of 100 with DBS and 32 out of 100 with medicine. [8]
- Quality of life. In 156 people under 75 with severe movement problems, quality of life improved more with DBS than with medicine at 6 months. Serious events were also more common (13 vs 4 out of 100). [10]
- Earlier stage. In 251 people with early motor problems (average age 52), quality of life improved over 2 years with DBS but not with medicine alone. [11]
- Tremor. In a trial of 68 people with severe tremor, thalamic DBS stopped or nearly stopped tremor in 30 of 33 people. [12]
Risks and complications
Serious or lasting risks
- Serious events overall. In the 255-person trial, 49 of 121 people with DBS had a serious adverse event, vs 15 of 134 on medicine. One person died from brain bleeding. [8] In the earlier stage trial, about 18 out of 100 had a serious event from surgery or the device. [11]
- Rates from 262 studies (21,261 people with Parkinson's disease), out of 100 people: infection about 4, lead in the wrong place about 3, bleeding about 2, other hardware problems about 2, and seizures about 2. About 5 out of 100 needed a repeat operation. [13]
- Thinking and mood. Small declines in some thinking speed tests and more low mood were seen after DBS than with medicine. [8]
Effects that may come and go
- Speech. In the first 3 months, 12 of 121 people had a speech problem. [8] Speech, balance, or swallowing changes often come from the settings and may improve with adjustment. [2]
Limits of the evidence. A 2024 review of 7 trials rated the evidence as very low certainty. DBS raised serious adverse events, mainly from surgery and hardware. [14]
Battery and device care. A standard battery lasts about 3 to 5 years. A rechargeable one lasts about 9 years. A failed battery must be replaced. Parts can break or move. [1]
MRI cautions. Some devices allow MRI only under certain conditions. A device with unknown MRI safety should be treated as unsafe. Always tell the MRI staff you have a DBS system. [15]
Alternatives
- Changing the type, dose, or timing of medicine. [16]
- Lesion procedures, such as MRI-guided focused ultrasound, for selected people with tremor. [4] [17]
- Choosing not to have surgery.
Recovery and follow-up
Programming. The device is usually turned on a few weeks after surgery. Programming finds settings that help symptoms with few side effects. Some centers schedule visits every 1 to 2 months for the first 6 months. Later, many people need 1 or 2 visits a year. [2] Most people still take medicine, often at a lower dose. [1]
Call your surgeon for fever, redness at a cut, new weakness, or speech or vision trouble. [1] Any change in your medicine should come from your treating team. Recovery varies. Follow the discharge instructions from your own team.
Questions to ask
- Which of my symptoms should DBS help, and which not?
- Which target do you suggest for me, and why?
- How many programming visits will I need?
- Should I choose a rechargeable battery, and can I have MRI scans later?
Sources
- Deep brain stimulation. MedlinePlus Medical Encyclopedia. US National Library of Medicine. Published October 27, 2025. Open source
- Deep Brain Stimulation. Parkinson's Foundation. Open source
- Follett KA, Weaver FM, Stern M, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med. 2010;362(22):2077-2091. Published June 3, 2010. Open source
- Essential Tremor. National Institute of Neurological Disorders and Stroke (NINDS). Open source
- Fisher R, Salanova V, Witt T, et al. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia. 2010;51(5):899-908. Published March 17, 2010. Open source
- Premarket Approval P960009: Medtronic Activa Tremor Control System. US Food and Drug Administration. Published July 31, 1997. Open source
- Parkinson's Disease. National Institute of Neurological Disorders and Stroke (NINDS). Open source
- Weaver FM, Follett K, Stern M, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA. 2009;301(1):63-73. Published January 7, 2009. Open source
- Deep Brain Stimulation. American Association of Neurological Surgeons (AANS). Published April 15, 2024. Open source
- Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med. 2006;355(9):896-908. Published August 31, 2006. Open source
- Schuepbach WMM, Rau J, Knudsen K, et al. Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med. 2013;368(7):610-622. Published February 14, 2013. Open source
- Schuurman PR, Bosch DA, Bossuyt PM, et al. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med. 2000;342(7):461-468. Published February 17, 2000. Open source
- Rasiah NP, Maheshwary R, Kwon CS, Bloomstein JD, Girgis F. Complications of deep brain stimulation for Parkinson disease and relationship between micro-electrode tracks and hemorrhage: systematic review and meta-analysis. World Neurosurg. 2023;171:e8-e23. Published October 13, 2022. Open source
- Petersen JJ, Kamp CB, Faltermeier P, et al. Deep brain stimulation for Parkinson's disease: systematic review with meta-analysis and trial sequential analysis. BMJ Med. 2024;3(1):e000705. Published August 16, 2024. Open source
- MRI (Magnetic Resonance Imaging): Benefits and Risks. US Food and Drug Administration. Open source
- Parkinson disease. MedlinePlus Medical Encyclopedia. US National Library of Medicine. Published January 27, 2026. Open source
- FDA Approves Insightec Exablate Neuro to Treat Second Side of Essential Tremor. NeurologyLive. December 21, 2022. Published December 21, 2022. Open source